Pfizer Finance Mgr In India Blows Whistle
1 CommentBy Ed Silverman // May 16th, 2007 // 6:24 pm

The latest whistleblower to tell his tale to Peter Rost, the former Pfizer exec-cum-whistleblower who now spends his time blogging and writing books, is a former deputy finance manager in Pfizer’s finance division in Mumbai, India.
He has a complicated tale about discovering that the sale of a Pfizer plant in Hyderabad went for a fraction of its real value, raising suspicions of kickbacks. Ashok Idnani also alleges there were accounting irregularties, and that an internal investigation, which he tried to propel, was stifled by Pfizer execs in India and New York.
Then, after nearly three years of pushing, Idnani was fired. A month later, in September 2006, he detailed his allegations in an e-mail to Jeff Kindler, who is now Pfizer’s ceo; Karen Katen, vice chair; David Shedlarz, another vice chair; Alan Levin, cfo, and Sylvia Montero, senior vp for human resources, and copied to Pfizer’s board.
There are a few documents to view at Rost’s site. And over the next two days, Rost promises two more installations in this mini-series that will feature detectives hired to follow Pfizer shareholders and a former executive, and documents allegedly showing how Pfizer bribed government officials. Oh yes, there was also voodoo in the finance department.
Read the full story.
[tags]India, Peter Rost, Pfizer, Whistleblower[/tags]
Finan
Ed,
You refer to Peter Rost, the former Pfizer exec-cum-whistleblower.
Exec-cum-whistle, maybe, but exec-cum-whistleblower? Literally, that would be exec-with-whistleblower!
Unless your appositive has other, quasi-academic roots, and you mean to suggest an executive, who “graduated†Pfizer (and whatever previous employer it was where he also took followed his noble join-and-blow strategy) with whistleblower honors. In the present usage, I believe your construction fails building inspection.
Respectfully,
Finan